Pleiotrophin inhibits chondrocyte proliferation and stimulates proteoglycan synthesis in mature bovine cartilage.
Pleiotrophin (PTN) is a secreted heparin-binding, developmentally regulated protein that is found in abundance in fetal, but not mature, cartilage. SDS-page and glycosaminoglycan (GAG) analysis of sulfate-radiolabeled proteoglycans isolated from the medium of mature cultured chondrocytes treated with PTN showed a threefold increase in the levels of proteoglycan synthesis. In contrast, in cultures of fetal chondrocytes, no changes in proteoglycan synthesis were observed. Thymidine incorporation experiments showed a dose-dependent decrease in proliferation of treated cells compared with control cultures, suggesting that pleiotrophin had an inhibitory effect on growth of chondrocytes. Neither FGF or heparin reversed the inhibitory effect of PTN. Capillary electrophoresis of chondroitinase ABC-digested proteoglycans isolated from mature chondrocytes showed 2-4-fold increases in the amounts of the 4S- and 6S-substituted GAG chains for the PTN-treated chondrocytes. Northern analysis showed a twofold upregulation in the mRNA levels of biglycan and collagen type II, but no difference in the message levels for decorin and aggrecan. These results establish that PTN inhibits cell proliferation, while stimulating the synthesis of proteoglycans in mature chondrocytes in vitro, suggesting that PTN may act directly or indirectly to regulate growth and proteoglycan synthesis in the developing matrix of fetal cartilage.
Tapp
H
H
Shriners Hospital for Children, 12502 N. Pine Dr., Tampa, FL 33612, USA.
Hernandez
D J
DJ
Neame
P J
PJ
Koob
T J
TJ
D000818:Animals; D000831:Animals, Newborn; D001483:Base Sequence; D058578:Biglycan; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D002358:Cartilage, Articular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D019765:Chondroitin ABC Lyase; D003094:Collagen / Q000235:genetics; D016207:Cytokines / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D017931:DNA Primers / Q000235:genetics; D016326:Extracellular Matrix Proteins; D005333:Fetus / Q000166:cytology; D006025:Glycosaminoglycans / Q000096:biosynthesis / Q000302:isolation & purification; D011509:Proteoglycans / Q000096:biosynthesis* / Q000235:genetics / Q000302:isolation & purification; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins / Q000235:genetics / Q000494:pharmacology
D058578:Biglycan; D002352:Carrier Proteins; D016207:Cytokines; D017931:DNA Primers; D016326:Extracellular Matrix Proteins; D006025:Glycosaminoglycans; D011509:Proteoglycans; D012333:RNA, Messenger; D011994:Recombinant Proteins; C066845:pleiotrophin; D003094:Collagen; D019765:Chondroitin ABC Lyase